No abstract

No abstract

Purpose: To evaluate the differences in overall cost between two common treatments of Hepatocellular Carcinoma; Y-90 and trans arterial chemoembolization (TACE). Materials: Retrospective study of patients at Einstein medical center who received either Y-90 or TACE for treatment of hepatocellular carcinoma. The number of treatments per patient was obtained from a chart review. Cost of the procedures and hospital admission was obtained from the hospital chargemaster. The primary outcome was the overall difference in cost between Y-90 vs TACE for treatment of hepatocellular carcinoma at Einstein Medical Center.

No abstract